United States · FDA National Drug Code directory
CYCLOBENZAPRINE HYDROCHLORIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51655-592_49612fd2-0c18-42a0-e063-6394a90a00fc
- Product NDC
- 51655-592
- Form
- TABLET, FILM COATED
- Composition / generic term
- cyclobenzaprine hydrochloride
- Labeler
- Northwind Health Company, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230103
- Source listing expiry
- 20271231
Source-listed ingredients
- CYCLOBENZAPRINE HYDROCHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51655-592-20) · 51655-592-20
- 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51655-592-25) · 51655-592-25
- 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51655-592-26) · 51655-592-26
- 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51655-592-52) · 51655-592-52
- 10 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51655-592-53) · 51655-592-53
- 15 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51655-592-54) · 51655-592-54
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →